Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections

We evaluated second-line salvage therapy with adefovir + telbivudine (group 1), adefovir followed by adefovir + telbivudine (group 2), or lamivudine + adefovir followed by adefovir + telbivudine (group 3) in hepatitis B patients with an inadequate virologic response to lamivudine treatment. Simple l...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ming-Tsung, Chou, Yeh-Pin, Hu, Tsung-Hui, Yu, Hsien-Chung, Hsu, Yu-Chun, Tsai, Ming-Chao, Tseng, Po-Lin, Chang, Kuo-Chin, Yen, Yi-Hao, Chiu, King-Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888503/
https://www.ncbi.nlm.nih.gov/pubmed/23857507
http://dx.doi.org/10.1007/s00705-013-1786-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888503/
https://www.ncbi.nlm.nih.gov/pubmed/23857507
http://dx.doi.org/10.1007/s00705-013-1786-4

Ejemplares similares